. "Early epidemiology data suggested that even ATM heterozygosity might elevate the risk of death from cardiovascular disease.109 Schneider et al105 also showed that ATM haploinsufficiency accelerated diet-induced atherosclerotic lesions in apoE null mice, along with other features associated with the metabolic syndrome, including insulin resistance and glucose intolerance." . . . .